Anatara Lifesciences Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2016 - 2020
Other Revenue	0.97	0.64	-	-	-	Upgrade
Revenue	0.97	0.64	-	-	-	Upgrade
Revenue Growth (YoY)	50.53%	-	-	-	-	Upgrade
Cost of Revenue	1.6	0.75	1.6	0.75	0.84	Upgrade
Gross Profit	-0.63	-0.1	-1.6	-0.75	-0.84	Upgrade
Selling, General & Admin	1.32	1.35	1.68	2.28	2.27	Upgrade
Other Operating Expenses	-	-	-1.24	-0.49	-1.07	Upgrade
Operating Expenses	1.32	1.35	0.44	1.79	1.2	Upgrade
Operating Income	-1.96	-1.46	-2.05	-2.53	-2.04	Upgrade
Interest Expense	-0.01	-	-0	-0	-0	Upgrade
Interest & Investment Income	0.01	0.01	0.02	0.01	0.01	Upgrade
EBT Excluding Unusual Items	-1.95	-1.45	-2.03	-2.53	-2.03	Upgrade
Other Unusual Items	-	-	0.01	-	0.04	Upgrade
Pretax Income	-1.95	-1.45	-2.02	-2.53	-2	Upgrade
Net Income	-1.95	-1.45	-2.02	-2.53	-2	Upgrade
Net Income to Common	-1.95	-1.45	-2.02	-2.53	-2	Upgrade
Shares Outstanding (Basic)	205	150	98	71	63	Upgrade
Shares Outstanding (Diluted)	205	150	98	71	63	Upgrade
Shares Change (YoY)	36.45%	53.21%	37.65%	13.44%	26.25%	Upgrade
EPS (Basic)	-0.01	-0.01	-0.02	-0.04	-0.03	Upgrade
EPS (Diluted)	-0.01	-0.01	-0.02	-0.04	-0.03	Upgrade
Free Cash Flow	-2.27	-1.25	-2.26	-2.24	-2.1	Upgrade
Free Cash Flow Per Share	-0.01	-0.01	-0.02	-0.03	-0.03	Upgrade
Gross Margin	-65.39%	-16.29%	-	-	-	Upgrade
Operating Margin	-201.83%	-226.56%	-	-	-	Upgrade
Profit Margin	-201.63%	-225.34%	-	-	-	Upgrade
Free Cash Flow Margin	-234.36%	-193.69%	-	-	-	Upgrade
EBITDA	-1.96	-1.46	-2.02	-2.51	-2.04	Upgrade
EBITDA Margin	-201.76%	-226.18%	-	-	-	Upgrade
D&A For EBITDA	0	0	0.02	0.02	0.01	Upgrade
EBIT	-1.96	-1.46	-2.05	-2.53	-2.04	Upgrade
EBIT Margin	-201.83%	-226.56%	-	-	-	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.